310 related articles for article (PubMed ID: 7727053)
21. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR
Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes.
Buchanan DR; Collier A; Rodrigues E; Millar AM; Gray RS; Clarke BF
Eur J Clin Pharmacol; 1988; 34(1):51-3. PubMed ID: 3282895
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of alpha-glucosidase inhibition.
Bischoff H
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
[TBL] [Abstract][Full Text] [Related]
24. Acarbose in ambulatory treatment of non-insulin-dependent diabetes mellitus associated to imminent sulfonylurea failure: a randomised-multicentric trial in primary health-care. Diabetes and Acarbose Research Group.
Costa B; Piñol C
Diabetes Res Clin Pract; 1997 Oct; 38(1):33-40. PubMed ID: 9347244
[TBL] [Abstract][Full Text] [Related]
25. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
Gendeleka GF
Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
[TBL] [Abstract][Full Text] [Related]
26. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
Johansen K
Diabete Metab; 1984 Oct; 10(4):219-23. PubMed ID: 6391973
[TBL] [Abstract][Full Text] [Related]
27. The use of acarbose in the prevention and treatment of hypoglycaemia.
Lefebvre PJ; Scheen AJ
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():40-4. PubMed ID: 8001627
[TBL] [Abstract][Full Text] [Related]
28. Acarbose and insulin therapy in type I diabetes mellitus.
Rios MS
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():36-9. PubMed ID: 8001626
[TBL] [Abstract][Full Text] [Related]
29. Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.
Coniff RF; Shapiro JA; Seaton TB
Arch Intern Med; 1994 Nov; 154(21):2442-8. PubMed ID: 7979840
[TBL] [Abstract][Full Text] [Related]
30. [Acarbose, an unduly neglected antidiabetic drug].
Iványi J; Gyimesi A
Orv Hetil; 1996 Dec; 137(49):2737-41. PubMed ID: 9679608
[TBL] [Abstract][Full Text] [Related]
31. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
[TBL] [Abstract][Full Text] [Related]
32. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
Scheen AJ
Drugs; 2003; 63(10):933-51. PubMed ID: 12699398
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of acarbose as monotherapy in NIDDM patients.
Deerochanawong C; Serirat S; Kornthong P
J Med Assoc Thai; 1996 Feb; 79(2):69-75. PubMed ID: 8868016
[TBL] [Abstract][Full Text] [Related]
34. Management of non-insulin-dependent diabetes mellitus.
Lefèbvre PJ; Scheen AJ
Drugs; 1992; 44 Suppl 3():29-38. PubMed ID: 1280575
[TBL] [Abstract][Full Text] [Related]
35. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
Dimitriadis GD; Tessari P; Go VL; Gerich JE
Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
[TBL] [Abstract][Full Text] [Related]
36. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
Welborn TA
Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
[No Abstract] [Full Text] [Related]
37. Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor.
Füessl HS; Adrian TE; Uttenthal LO; Bloom SR
Klin Wochenschr; 1988 Oct; 66(19):985-9. PubMed ID: 3054280
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
Scheen AJ
Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
[TBL] [Abstract][Full Text] [Related]
39. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
[TBL] [Abstract][Full Text] [Related]
40. European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses.
Fischer S; Hanefeld M; Spengler M; Boehme K; Temelkova-Kurktschiev T
Acta Diabetol; 1998 Apr; 35(1):34-40. PubMed ID: 9625287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
